Hamrick Investment Counsel’s Cardinal Health CAH Stock Holding History

Hamrick Investment Counsel’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$423	–	213
2026 Q1	$423	Buy	+2	New	+$431	﹤0.01%	351

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Hamrick Investment Counsel's CAH Position: Q2 2026 in Review

Hamrick Investment Counsel sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 2 shares — an estimated $423 sold.

Hamrick Investment Counsel first reported a position in CAH in Q1 2026 and held it in 1 quarter. The position peaked at $423 in Q1 2026. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Hamrick Investment Counsel reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
Hamrick Investment Counsel sold 2 Cardinal Health shares in Q2 2026, an estimated $423.
Hamrick Investment Counsel first reported a position in Cardinal Health in Q1 2026 and held it in 1 quarter.
Hamrick Investment Counsel's Cardinal Health position peaked at $423 in Q1 2026.
1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Hamrick Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.